ENDURANCE: Post Approval Effectiveness and Durability Evaluation of the Altaviva Tibial Device

Enrolling By Invitation
99 years or below
All
Phase N/A
10 participants needed
1 Location

Brief description of study

This is a prospective, multicenter, single-arm, open-label study to assess the long-term safety and effectiveness of AltavivaTM system for treatment of urinary incontinence (UUI).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 23 Jun 2026. Study ID: 26-6730
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research